Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
LY3305677 Phase 2 Results Expected
LY3305677 • Obesity
Target Indication
Obesity
Clinical Trial
Last updated: 12/5/2025
LLY
Eli Lilly and Company
